The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.

Investors will be looking for a path to a turnaround from UnitedHealth’s earnings release, after an abrupt CEO change and ...

The conglomerate was viewed as one of the most successful companies in America, but patients are enraged and investors have ...

Luigi Mangione’s recent courtroom revelations send chilling ripples through the heart of America, underscoring a troubling trend where political violence is increasingly rationalized by radical minds.